Mara C Modzeski, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 132 Abigail Ln, Port Matilda, PA 16870 Phone: 814-272-5011 Fax: 814-272-6531 |
Dr. Evan James Harlor, D.O. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 132 Abigail Ln, Port Matilda, PA 16870 Phone: 814-272-5011 Fax: 814-272-6531 |
Dr. Henry Cramer, M.D. Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 132 Abigail Lane, Port Matilda, PA 16870 Phone: 814-272-5011 Fax: 814-272-6531 |
News Archive
BrainStorm Cell Therapeutics, a leading developer of adult stem cell technologies for neurodegenerative diseases, announced today that the first patient began treatment in the Company's Phase IIa dose-escalating clinical trial for ALS.
Medulloblastoma is the most common type of solid brain tumor in children. Current treatments offer limited success and may leave patients with severe neurological side effects, including psychiatric disorders, growth retardation and cognitive impairment.
Medication non-adherence, persistent substance use disorder, carers' critical comments, and poorer premorbid adjustment are significant predictors for relapse in patients treated for a first episode of psychosis, a review and meta-analysis of published studies shows.
A University of Minnesota research team was recently awarded two grants totaling more than $3 million from the National Science Foundation's Cyber-Enabled Discovery and MRI Programs to create robotic devices and computer vision algorithms that will assist with the early diagnosis of children at risk of developing disorders such as autism, attention deficit disorder and obsessive compulsive disorder.
› Verified 9 days ago